Generated by GPT-5-mini| Centrosome | |
|---|---|
| Name | Centrosome |
| Location | Cytoplasm |
| Function | Microtubule organization center, spindle assembly |
| Components | Centrioles, pericentriolar material |
Centrosome The centrosome is a major eukaryotic microtubule-organizing center that coordinates cell polarity, mitotic spindle formation, and intracellular trafficking. It typically comprises a pair of centrioles surrounded by pericentriolar material and interacts with kinetochores, the mitotic spindle apparatus, and the cytoskeleton during the cell cycle. Centrosome dysfunction is implicated in cancer, ciliopathies, and developmental disorders, and its composition and behavior vary across taxa such as animals, fungi, and protists.
The canonical centrosome contains a pair of orthogonally arranged centrioles embedded in an amorphous matrix called the pericentriolar material (PCM), which nucleates and anchors microtubules through gamma-tubulin complexes; variations appear in organisms studied by researchers at institutions like the Max Planck Society and Cold Spring Harbor Laboratory. Centrioles are cylindrical structures with ninefold symmetry of microtubule triplets or doublets, a geometry characterized in studies linked to Theodor Boveri and visualized using methods developed at EMBL and NIH microscopy cores. The PCM contains scaffold and regulatory proteins such as pericentrin and CDK5RAP2, identified in genetic screens comparable to screens performed at Howard Hughes Medical Institute-funded labs and cataloged in databases maintained by the European Molecular Biology Laboratory.
Centrosomes serve as the primary microtubule-organizing centers during interphase and mitosis, organizing radial microtubule arrays studied in classic experiments at Max Planck Institute for Biophysical Chemistry and invoked in models from labs at MIT and Stanford University; they anchor motor proteins like dynein and kinesin that mediate vesicle transport to organelles such as the Golgi apparatus and endoplasmic reticulum. During mitosis, centrosomes nucleate spindle poles and interact with kinetochores to ensure chromosome segregation, a process dissected using mutants in organisms like Drosophila melanogaster, Caenorhabditis elegans, and Xenopus laevis and investigated in clinical contexts at centers including Johns Hopkins Hospital. Centrosomes also organize cilia and flagella through basal body conversion, a transition studied in model systems such as Chlamydomonas reinhardtii and linked to human disorders described in reports from institutions like Mayo Clinic.
Centrosome duplication is tightly coordinated with the cell cycle and involves licensing, procentriole formation, elongation, and maturation phases controlled by proteins studied in laboratories at University of California, San Francisco and Harvard Medical School; misregulation can lead to centrosome amplification documented in cancer cohorts analyzed by teams at Memorial Sloan Kettering Cancer Center. Duplication initiates in S phase with recruitment of scaffold proteins and assembly of procentrioles adjacent to existing centrioles, relying on kinases such as PLK4 and CDK2 revealed by genetic and pharmacological studies at institutions including University College London and Dana-Farber Cancer Institute. Centriole disengagement during anaphase, regulated by separase and other factors characterized in work from Rockefeller University, licenses a new round of duplication, and centrosome maturation before mitosis increases PCM size to boost microtubule nucleation as shown in experiments from European Molecular Biology Laboratory (EMBL) teams.
Key structural proteins include tubulin isoforms, gamma-tubulin ring complex components such as GCP2 and GCP3, and scaffold proteins like pericentrin and CDK5RAP2 identified through screens at Wellcome Trust Sanger Institute and other centers; regulatory enzymes include kinases PLK4, Aurora A, and CDK2 studied in drug discovery programs at Pfizer and academic consortia. PCM assembly depends on oligomeric scaffolds such as Cep192 and interactors discovered in proteomic surveys from European Bioinformatics Institute collaborations, while centriole cartwheel proteins such as SAS-6 and STIL define ninefold symmetry in studies pioneered by groups at University of Geneva and Cold Spring Harbor Laboratory. Centrosomes also recruit microtubule-associated proteins (MAPs) and motors, including dynein cofactors characterized in projects affiliated with NIH and EMBO-supported networks.
Centrosome amplification, loss, or structural defects are observed in many tumors and are associated with chromosomal instability in cohorts analyzed by cancer centers like MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center; mutations in centrosomal genes cause congenital microcephaly syndromes traced to genes such as ASPM and CDK5RAP2 in studies from Broad Institute consortia. Defects in centrosome-to-basal body conversion underlie ciliopathies including Bardet–Biedl syndrome and Joubert syndrome, with patient registries and clinical genetics programs at centers such as Cleveland Clinic reporting genotype–phenotype correlations. Drugs targeting centrosome regulators, including PLK4 inhibitors developed in collaborations between academic labs and pharmaceutical companies like AstraZeneca, are in preclinical and clinical evaluation for cancer therapy.
Centrosome architecture and reliance vary: animals and many protists use centriolar centrosomes, fungi such as Saccharomyces cerevisiae harbor spindle pole bodies functionally analogous to centrosomes, and some plants and amoebozoans organize microtubules without centrioles as noted in comparative studies from institutions like Smithsonian Institution and Royal Society. Evolutionary analyses leveraging genomes from projects at Genome Institute at Washington University and comparative work by researchers at University of Cambridge reveal conserved centriole components (e.g., SAS-6) and lineage-specific innovations linked to multicellularity and ciliation observed across taxa including Drosophila, Arabidopsis thaliana, and diverse protists. Paleobiological and phylogenomic studies coordinated with museums such as the Natural History Museum, London integrate fossil and molecular data to infer the ancient origins and diversification of centrosome-related structures.